Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 6626 - 6650 of 10704 in total
Experimental
Matched Iupac: … (4S)-2,6-dioxo-1,3-diazinane-4-carboxylic acid …
Experimental
Matched Name: … 2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide …
Matched Iupac: … 2-(3-methoxyphenyl)-1H-1,3-benzodiazole-4-carboxamide …
Vet approved
Matched Iupac: … 4-amino-6-(1,2,2-trichloroethenyl)benzene-1,3-disulfonamide …
Emeramide has been used in trials studying the treatment of Mercury Poisoning.
Investigational
Matched Iupac: … N1,N3-bis(2-sulfanylethyl)benzene-1,3-dicarboxamide …
Experimental
Matched Name: … 1-Amino-6-Cyclohex-3-Enylmethyloxypurine …
CPI-1189 has been used in trials studying the treatment of HIV Infections and AIDS Dementia Complex.
Investigational
Lym-1-I-131 is a monoclonal antibody labeled with iodine-131 (131I) that preferentially targets malignant lymphocytes.
Investigational
Matched Synonyms: … Monoclonal antibody LYM-1-I-131 ... Murine MAb (Lym-1) and Iodine 131-I radiolabeled murine MAb (Lym-1) to human B-cell lymphoma ... Iodine I 131 Lym-1 Monoclonal Antibody …
Matched Name: … Lym-1-I-131 …
Matched Description: … Lym-1-I-131 is a monoclonal antibody labeled with iodine-131 (131I) that preferentially targets malignant …
VB10.16 is a novel therapeutic antigen-presenting cell-targeting DNA vaccine developed to treat HPV16-positive cancers. It is composed of three parts, one encodes the E6/E7 fusion protein of human papillomavirus (HPV) type 16 (HPV16), a dimerization entity, and the part encoding a protein that specifically binds to antigen-presenting cells (APCs).
Investigational
Experimental
Matched Name: … 3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl …
Matched Iupac: … 3-{3-[(1S,5S,6R,7S,9S,10S)-5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1^{7,10}.0^{1,6}]tridecan-5-yl]propanamido …
A malonic acid derivative which is a vital intermediate in the metabolism of fat and protein. Abnormalities in methylmalonic acid metabolism lead to methylmalonic aciduria. This metabolic disease is attributed to a block in the enzymatic conversion of methylmalonyl CoA to succinyl CoA. [PubChem]
Experimental
Experimental
Matched Name: … (1R)-2-[(Diaminomethylene)amino]-1-{4-[(4R)-4-(hydroxymethyl)-1,3,2-dioxaborolan-2-yl]phenyl}ethyl nicotinate …
Matched Iupac: … pyridine-3-carboxylate ... (1R)-2-[(diaminomethylidene)amino]-1-{4-[(4R)-4-(hydroxymethyl)-1,3,2-dioxaborolan-2-yl]phenyl}ethyl …
Samatasvir has been used in trials studying the treatment of Hepatitis C, Chronic, Chronic Hepatitis C Virus, and Chronic Hepatitis C Infection.
Investigational
Matched Iupac: … methyl N-[(1R)-2-[(2S)-2-{5-[4-(6-{2-[(2S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl]pyrrolidin ... -2-yl]-1H-1,3-benzodiazol-6-yl}thieno[3,2-b]thiophen-3-yl)phenyl]-1H-imidazol-2-yl}pyrrolidin-1-yl]-2 ... -oxo-1-phenylethyl]carbamate …
Azeliragon has been used in trials studying the treatment of Alzheimer's Disease.
Investigational
Matched Iupac: … [3-(4-{2-butyl-1-[4-(4-chlorophenoxy)phenyl]-1H-imidazol-4-yl}phenoxy)propyl]diethylamine …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Quisinostat has been used in trials studying the treatment of Lymphoma, Neoplasms, Myelodysplastic Syndromes, and Advanced or Refractory Leukemia.
Investigational
Matched Iupac: … N-hydroxy-2-[4-({[(1-methyl-1H-indol-3-yl)methyl]amino}methyl)piperidin-1-yl]pyrimidine-5-carboxamide …
IDD-3 is a therapeutic specific immunostimulant developed by IDM Pharma in partnership with sanofi-aventis. It consists of mature dendritic cells loaded with lysates from melanoma tumor cell lines. It includes Dendritophages that are dendritic cells, a type of specialized immune cells derived from the patient's own white blood cells.
Investigational
Matched Name: … IDD-3
Matched Description: … IDD-3 is a therapeutic specific immunostimulant developed by IDM Pharma in partnership with sanofi-aventis …
A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from glycine or threonine. It is involved in the biosynthesis of purines; pyrimidines; and other amino acids.
Investigational
Nutraceutical
Matched Synonyms: … (S)-2-Amino-3-hydroxypropanoic acid …
Matched Iupac: … (2S)-2-amino-3-hydroxypropanoic acid …
Matched Mixtures name: … AMINOMIX 3 SOLÜSYON, 1000 ML ... AMINOMIX 3 SOLÜSYON, 2000 ML ... AMINOMIX 3 SOLÜSYON, 15000 ML …
SynOV1.1 is an investigational cancer immunotherapy developed by SyngenTech. It is a recombinant oncolytic adenovirus, controlled by synthetic gene circuit, encoding the human immunostimulating factor cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF). SynOV1.1 is under investigation in clinical trial NCT04612504 (Synov1.1 Intratumoral Injection Study).
Investigational
Experimental
Matched Name: … 2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid …
Matched Iupac: … (3R)-2-{[1,1'-biphenyl]-4-sulfonyl}-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid …
Experimental
Matched Name: … 3-OXO-N-[(3S)-2-OXOPYRROLIDIN-3-YL]DODECANAMIDE …
Matched Iupac: … 3-oxo-N-[(3S)-2-oxopyrrolidin-3-yl]dodecanamide …
Experimental
Matched Iupac: … [(2S,4aS,6S,7aS)-6-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-2-phenyl-hexahydrofuro[3,2-d ... ][1,3]dioxin-2-yl]phosphonic acid …
Galicaftor is under investigation in clinical trial NCT03540524 (A Study Looking at the Safety, Tolerability and Efficacy of the Combination of the Study Drugs GLPG2451 and GLPG2222 With or Without GLPG2737 in Patients With Cystic Fibrosis.).
Investigational
Matched Iupac: … 4-[(2R,4R)-4-[1-(2,2-difluoro-2H-1,3-benzodioxol-5-yl)cyclopropaneamido]-7-(difluoromethoxy)-3,4-dihydro ... -2H-1-benzopyran-2-yl]benzoic acid …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Experimental
Matched Name: … 1-3 Sugar Ring of Pentamannosyl 6-Phosphate …
Potent reversible inhibitor of phenylethanolamine N-methyltransferase.
Experimental
Displaying drugs 6626 - 6650 of 10704 in total